Lisdexamfetamine 40 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB26FULZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,981
Award facts
- Contract value 100% obligated
- $4,980.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) with a ceiling value of $4,980.60. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract under open competition. The order is set for ultimate completion by November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a critical role in the federal medical procurement supply chain. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Lisdexamfetamine represents one of numerous small-to-medium value transactions the company fulfills through its prime vendor agreement, supporting the military's pharmaceutical supply requirements. The DLA is planning to establish the next generation of Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen to continue serving as a critical supplier of essential medications for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FULZT?
SPE2DB26FULZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FULZT worth?
The government has obligated $4,981 on SPE2DB26FULZT.
Is contract SPE2DB26FULZT an order under another contract?
Yes. SPE2DB26FULZT is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB26FULZT competed?
The extent of competition for SPE2DB26FULZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award